Journal profile · PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Journal of Multimorbidity and Comorbidity
ISSN 2633-5565
Journal of Multimorbidity and Comorbidity: CAS Zone 3 · Medicine (2026 Xinrui edition); impact factor 2.7 (journal website); fully open access; APC about USD 1,575; median 151 days to acceptance (83 articles, last 24 months); 41 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
Journal of Multimorbidity and Comorbidity is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Chronic Disease Management Strategies, Primary Care and Health Outcomes and Diabetes Management and Education, together about 59% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Formerly the Journal of Comorbidity, the Journal of Multimorbidity and Comorbidity is an international, peer-reviewed, open access journal, which focuses on original clinical and experimental research articles on the pathophysiology, prevention, diagnosis and management of comorbidity and multimorbidity. View full journal description
From the journal's Aims & Scope
Research area (LetPub): PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Editor-in-chief Christopher HarrisonPublisher website
Editorial board by country: 2 in mainland China (about 5%); most named United Kingdom 7, Ireland 7, Sweden 5, Spain 4, Australia 4 (44 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Disease Management StrategiesMedicine37.7%
- Primary Care and Health OutcomesHealth Professions11.6%
- Diabetes Management and EducationMedicine9.7%
- Interprofessional Education and CollaborationHealth Professions4.7%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance3.1%
- Machine Learning in HealthcareComputer Science3.1%
- Heart Failure Treatment and ManagementMedicine2.8%
- Frailty in Older AdultsMedicine2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Public, Environmental & Occupational Health | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.7Publisher website ·
- h-index
- 20OpenAlex ·
- i10-index
- 49OpenAlex ·
- 2-year mean citedness
- 2.65OpenAlex ·
- Self-citation rate
- 3.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 40LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
Articles by year OpenAlex count · 197 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 42 | 42 | 11 |
| 2025 | 41 | 41 | 107 |
| 2024 | 27 | 27 | 174 |
| 2023 | 38 | 38 | 287 |
| 2022 | 29 | 29 | 755 |
| 2021 | 20 | 20 | 518 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
151 daysMedian, submission to acceptance · P25–P75 104 days – 261 days
- Acceptance to online
- median 29 days (83 articles)
- Submission to online
- median 197 days
- Sample
- 83 articles with submission and acceptance dates (85 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to publication (journal-reported)
- about 24 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,575 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 1,575 | — | — | |
| Publisher website | USD 2,250 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Manuscript length
- ≤ 5,000 words
- Reference style
- Vancouver
Article types accepted9, with length limits
- commentaryThe author may comment on/discuss a recent Journal of Multimorbidity and Comorbidity article to express his or her opinions, views and perspectives. The comment…main text ≤ 1,500 words
- editorialThe author may address virtually any important topic that is of interest to Journal of Multimorbidity and Comorbidity readers and within the scope of the journa…main text ≤ 800 words · references ≤ 5
- original articleView our Special Collections currently accepting submissions. Journal of Multimorbidity and Comorbidity considers all types of original articles specifically ad…main text ≤ 5,000 words
- original articlesJournal of Multimorbidity and Comorbidity considers all types of original articles specifically addressing comorbidity and multimorbidity. These articles includ…Length not stated
- protocolView our Special Collections currently accepting submissions. Journal of Multimorbidity and Comorbidity considers all types of original articles specifically ad…Length not stated
- reviewView our Special Collections currently accepting submissions. Journal of Multimorbidity and Comorbidity considers all types of original articles specifically ad…Length not stated
- review articleView our Special Collections currently accepting submissions. Journal of Multimorbidity and Comorbidity considers all types of original articles specifically ad…main text ≤ 250 words · abstract ≤ 250 words
- study protocolStudy protocol Journal of Multimorbidity and Comorbidity believes that publishing study protocols serves several important purposes: it increases research quali…Length not stated
- surveyView our Special Collections currently accepting submissions. Journal of Multimorbidity and Comorbidity considers all types of original articles specifically ad…Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Authorship
Please view our authorship policies, which includes information on criteria for authorship, who should be the corresponding author and more. Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- License & copyright
Manuscript content licensed under Creative Commons Licenses Model summary
Manuscript content on this site is licensed under Creative Commons Licenses
Source ↗Publisher website ·- Open access Publishing fees and open access
Online-only journal Model summary
Journal of Multimorbidity and Comorbidity is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publish…
Source ↗Publisher website ·- Peer review Peer review policy
Single anonymized peer review Model summary
The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- ISSN
- 2633-5565
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Multimorbidity and Comorbidity
What CAS zone is Journal of Multimorbidity and Comorbidity in?
In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Multimorbidity and Comorbidity?
The journal's website gives an impact factor of 2.7; this is the journal's own figure, as LetPub lists none for it; h-index 20.
How long does peer review take at Journal of Multimorbidity and Comorbidity?
Based on the dates recorded on 83 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 151 days (interquartile range 104–261 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Multimorbidity and Comorbidity?
According to the journal's author guidelines: Manuscript length: ≤ 5,000 words; Reference style: Vancouver. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Multimorbidity and Comorbidity based?
Of the 44 board members whose country the journal's board page names, 2 (about 5%) are in mainland China; the countries named most often are United Kingdom (7), Ireland (7) and Sweden (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Multimorbidity and Comorbidity?
According to LetPub and DOAJ records, Journal of Multimorbidity and Comorbidity is indexed in ESCI and DOAJ.
Is Journal of Multimorbidity and Comorbidity open access, and what is the APC?
Journal of Multimorbidity and Comorbidity is a fully open-access journal. APC about USD 1,575.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .